<?xml version="1.0" encoding="UTF-8"?>
<p>SARS-CoV-2 3CLpro was incubated with drugs at 0–100 µM for an hour at 37 °C. Then, 1.25 µM IQF peptide substrate was added to the mixture to a final volume of 100 µL and incubated at 37 °C for another three hours, prior to detection. With the same parameters applied in protease activity assays, the RFU readouts obtained from the SPARK® multimode microplate reader (TECAN, Switzerland) were normalised to the negative control (vehicle only) in each assay plate. After drug treatment at a concentration between 0–100 µM, points of relative protease activity were fitted to a normalised dose-response model in GraphPad Prism 7.03 for IC
 <sub>50</sub> characterisation, where 
 <inline-formula id="ilm0001">
  <alternatives>
   <inline-graphic xlink:href="IENZ_A_1850710_ILM0001.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   <math id="d2e365">
    <mi mathvariant="normal">Y</mi>
    <mo>=</mo>
    <mi mathvariant="normal">Bottom</mi>
    <mo>+</mo>
    <mfrac>
     <mrow>
      <mi mathvariant="normal">Top</mi>
      <mo>−</mo>
      <mi mathvariant="normal">Bottom</mi>
     </mrow>
     <mrow>
      <mn>1</mn>
      <mo>+</mo>
      <msup>
       <mrow>
        <mn>10</mn>
       </mrow>
       <mrow>
        <mo stretchy="true">(</mo>
        <mrow>
         <mi mathvariant="normal">LogIC</mi>
         <mn>50</mn>
         <mo>−</mo>
         <mi mathvariant="normal">X</mi>
        </mrow>
        <mo stretchy="true">)</mo>
        <mo>·</mo>
        <mi mathvariant="normal">HillSlope</mi>
       </mrow>
      </msup>
     </mrow>
    </mfrac>
   </math>
  </alternatives>
 </inline-formula> .
</p>
